Concomitant Tricuspid Valve Repair :

Size: px
Start display at page:

Download "Concomitant Tricuspid Valve Repair :"

Transcription

1 Concomitant Tricuspid Valve Repair : When to perform while awaiting data?! Steven F Bolling, MD Professor of Cardiac Surgery University of Michigan

2 Is FTR important? Decreased CO Fatigue, decreased exercise tolerance Right-sided Heart Failure Ascites, edema, decreased appetite, fullness FTR patients feel terrible Valve repair for functional tricuspid valve regurgitation: anatomical and surgical considerations Rogers JH, Bolling SF Semin Thorac Cardiovasc Surg ;22(1):84-9

3 and FTR patients die! FTR increases Mortality 5223 pts : Severe and Moderate TR increase mortality independent of PASP, LVEF, IVC size, RV size/ function. Nath. JACC 2004;43:405.

4 Severe and MODERATE FTR Decreases Survival Topilsky. JACC TR is bad. TR hurts quality of life and QUANTITY

5 Annular Dilation / Shape Change of FTR : %- all cases of MR!! Normal Tricuspid Annulus Fukuda. Circulation. 2006;114:I-492. Tricuspid Annulus with Functional TR

6 2017 -FTR is ignored! STS Database 60,000 MR + TR MR - 4,000,000 TR - 1,600, ,000 Annual New MR Annual MR Surgeries Annual TR Surgeries 8,000

7 Tricuspid repair when fixing MR Based on TR Grade 100 Percent of Patients Having Tricuspid Repair None Mild Moderate Severe Preoperative TR Grade Source: STS Database, N = V

8 When to look for FTR : Pre-op Functional TR dynamic! under anesthesia 4+ TR, can become mild Mean TR Grade Pre-Operative Pre-Bypass Post-Bypass Regard any previous significant TR or a dilated annulus as indications for TV repair! Frater (JTCVS 122:2001)

9 If in OR, don t just look for TR! Look for annulus > 40 mm RA, RV changes

10 FTR goes away by itself? 5589 MVr only cases (McCarthy, ATS 2004) Preop 16% had severe 3/4+ TR Discharge (MVR without TVr) 62% had residual severe TR! TR does not!

11 and despite a good mitral result King 1984 : 66 % 14 months Saafie 1985 : 35 % FTR post MVr Sagie 1994 Porter 1999 : 62 % FTR post MVr : 67 % 11 yrs No guarantee of FTR getting better!

12 Tricuspid Valve Repair 311 Patients MV Repair Preop TR % no/trace/mild 7 % moderate NONE Severe! Dreyfus Annals of Thoracic Surgery 2005

13 TR Does Not Just Go Away After MVr 311 undergoing MVr, mostly degenerative, all with dilated TV annulus TR Worsening by > 2 Grades % MVR only P< % MVR+TVR Dreyfus. Ann Thorac Surg 2005;79:127.

14 Adding TV repair adds risk 110 matched pts for MVr with FTR 8.5% - 30 day mortality, no TVr vs 2% - for MVr + TVr, p= 0.2 TR progression rate was 40% vs 5% 5-yr survival was 45% vs 74% Ann Thorac Surg Mar;87(3): Mitral valve surgery for functional mitral regurgitation: should moderate-or-more tricuspid regurgitation be treated? a propensity score analysis. Calafiore AM

15 Adding TV repair adds risk?

16 FTR - Don t Wait! Bernal (JTCVS 130:2005) Patients left with post-op FTR, when returned for redo TVr 30 day mortality was 35%! Highest op mortality in STS!!

17 How to fix FTR : New Repair Thinking for Functional TR Annuloplasty Rings DeVega DeVega. Rev Esp Cardiol 1972;25:6.

18 Use a Ring! Less recurrent TR and better Survival Freedom From Recurrent TR (%) Freedom From Death (%) 702 patients - TVR 493 DeVega 209 Ring Tang. Circulation 2006;114:I-577

19 Navia, JTCVS 2010 David JTCVS 2009

20 2 o FTR - Use a rigid ring! Carrier JHVD 13: patients for TV repairs Freedom from recurrence: Rigid ring - 94% Flexible - 72% DeVega - 66%

21 TV ring risks / fears AV Node injury Dehiscence Hemolysis Endocarditis

22 Classic Tricuspid Technique time to injure the AV node!

23 New How to : Anatomy of FTR Annular, RA, RV and LV geometry changes of TR

24 New FTR - Rule of TEN Triangle of Koch Taramasso JACC 2012

25 FTR repair - 10 Ten stitches - Ten minutes 10 o clock to 6 o clock

26 FTR - 10 stitches, 10 o clock to 6 o clock

27 How to size FTR Don t size! 26 / 28 RING

28 Pathophysiology of Functional / Secondary TR What size? NORMAL TRICUSPID ANNULAR DIMENSION cm! Sugimoto, T. J Thorac Cardiovasc Surg 1999;117:463-71

29 Undersized TV repair for FTR Actually RE-NORMAL size!

30 Undersized TV repair for FTR Preoperative None Mild Moderate Mod-to- Severe Severe Predischarge TR Grade None Mild Moderate Mod-to- Severe Severe Follow-up (mean = 1 yr) None Mild Moderate Mod-to- Severe Severe

31 Will I get Stenosis? NO! - Πr 2 26 mm = 4 cm mm gradient The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Rogers JH, Bolling SF. Circulation May 26;119(20):

32 RVEDV RVESV What about RV failure?

33 RVEF The RV gets better!

34 Tricuspid Annuloplasty Concomitant with Left-Sided Cardiac Surgery: Effects on Right Ventricular Remodeling Philippe B. Bertrand MD MSc ab, Gille Koppers MSc b, Frederik H. Verbrugge MD ab, Wilfried Mullens MD PhD ab, Rozette Reyskens RN a, Herbert Gutermann MD a, Chris Van Kerrebroeck MD PhD a, Robert Dion MD PhD a, Pieter Vandervoort MD ab, David Verhaert MD a a Department of Cardiovascular Medicine, Hospital Oost-Limburg, Genk, Belgium. b School of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium. J Thorac Cardiovasc Surg In press When FTR is fixed, the RV gets better!

35

36 Residual Tricuspid Insufficiency DON T LEAVE MOD TR!! Lack of reop is not the same as a good outcome!

37 I don t see these patients come back Mod TR Increases Mortality Nath. JACC 2004;43:405.

38 Fix TR if you are there? Current Guidelines for TV Surgery 2014 ACC/AHA Class I Severe TR in a patient undergoing left sided valve surgery Class IIa TV repair is beneficial for > Mild TR when there is tricuspid annular dilatation or right HF Class IIb TV repair considered for FTR in presence of PH or RV dilation/dysfunction 2012 ESC/EACTS Class I Severe TR in a patient undergoing left-sided valve surgery Class IIa Moderate 2nd TR with dilated tricuspid annulus (>40 mm) in a patient undergoing leftsided valve surgery or with RV dilation/dysfunction Data?

39 Far less TR, better RV NO mortality or PPM

40 Outcomes of Guideline directed Repair of FTR performed during MV surgery Ward, Romano, Bolling : AATS pts TVr, mod/sev or < moderate TR, 26/28/30 ring No mortality, No TS, RV improved 1% progression to severe TR, % de novo PPM rate

41 CTSNet TR Trial - 137/400 pts DMR repair Mod TR or mild TR with annular dilation > 40 Randomized: ±TV annuloplasty

42 Percutaneous data for TR?

43 FTR Surgery : Percutaneous Implications TV Perc Rings!

44 FTR: Percutaneous Not Rings

45 Tricuspid Regurgitation 4-TECH

46 Tricuspid Regurgitation Mitralign Trialign

47 FTR: Percutaneous other things More data needed

48 FTR: Data NOW! TR not important Look for TR in OR Not much TR around. Repair Mitral, TR goes away Adds operative mortality to do a TVr Don t know how to RV will fail Will get TS Won t make long-term difference Guidelines are vague NO NO NO NO NO NO NO NO NO NO FTR : Don t wait for more data

49 FTR: Put a ring on it!

Percutaneous technologies to correct TR : Myth or Reality? Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Percutaneous technologies to correct TR : Myth or Reality? Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan Percutaneous technologies to correct TR : Myth or Reality? Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan Disclosures Ownership Interest: Millipede and Pipeline TR is BAD Decreased

More information

Steven F Bolling Professor of Cardiac Surgery University of Michigan

Steven F Bolling Professor of Cardiac Surgery University of Michigan Optimal Treatment of Functional MR Steven F Bolling Professor of Cardiac Surgery University of Michigan Functional MR Functional MR in Ischemia Badhwar, Bolling, chapter in: Advances in Heart Failure,

More information

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Late secondary TR after left sided heart disease correction: is it predictibale and preventable Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary

More information

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan Degenerative MR is not Functional MR 2o - Functional MR : Ventricular Problem!!

More information

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for

More information

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions Percutaneous Tricuspid Valve Therapies: The Next Frontier? Scott M Lilly, MD PhD The Ohio State University Structural Heart Disease Course May 19 th, 2017 Outline Is the Tricuspid Valve Relevant? Data

More information

The Tricuspid Valve: The Not So Forgotten Valve. Manuel J Antunes Cardiothoracic Surgery Coimbra, Portugal

The Tricuspid Valve: The Not So Forgotten Valve. Manuel J Antunes Cardiothoracic Surgery Coimbra, Portugal The Tricuspid Valve: The Not So Forgotten Valve Manuel J Antunes Cardiothoracic Surgery Coimbra, Portugal No Conflicts of Interest to declare with regards to this subject 2 INCIDENCE OF TRICUSPID REGURGITATION

More information

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility

More information

Management of Tricuspid Regurgitation

Management of Tricuspid Regurgitation Management of Tricuspid Regurgitation Antonis A. Pitsis, FETCS, FESC Thessaloniki Heart Institute, St. Luke s Hospital, Thessaloniki, GREECE HEART FAILURE 2012 BELGRADE SERBIA Does Tricuspid Regurgitation

More information

I have financial relationships to disclose Honoraria from: Edwards

I have financial relationships to disclose Honoraria from: Edwards I have financial relationships to disclose Honoraria from: Edwards Mitral Valve Annuloplasty in Ischemic Mitral regurgitation Jean François Avierinos Hôpital Timone Marseille August 28, 2012 Ischemic MR

More information

What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA

What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA Contraindications for LVAD Lack of social support system Nonreversible end organ failure

More information

Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada

Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada PVR Following Repair of TOF Now? When? Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada Late Complications after TOF repair Repair will be necessary

More information

Atrioventricular valve repair: The limits of operability

Atrioventricular valve repair: The limits of operability Atrioventricular valve repair: The limits of operability Francis Fynn-Thompson, MD Co-Director, Center for Airway Disorders Surgical Director, Pediatric Mechanical Support Program Surgical Director, Heart

More information

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

The Key Questions in Mitral Valve Interventions. Where Are We in 2018? The Key Questions in Mitral Valve Interventions Where Are We in 2018? Gilles D. DREYFUS, MD, FRCS, FESC Professor of Cardiothoracic Surgery 30 GIORNATE CARDIOLOGICHE TORINESI - OCT 2018 Are guidelines

More information

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines Advances in Percutaneous Mitral Valve Repair and Replacement Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando,

More information

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun Clinical Outcome of Tricuspid Regurgitation David Messika-Zeitoun I have financial relationships to disclose Consultant for: Edwards, Symetis and Valtech Tricuspid Regurgitation is a Common Finding Tricuspid

More information

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL DISCLOSURES I WILL BE DISCUSSING OFF-LABEL USAGE OF DEVICES RELATED TO TMVR OBJECTIVES

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Understanding the guidelines for Interventions in MR. Ali AlMasood

Understanding the guidelines for Interventions in MR. Ali AlMasood Understanding the guidelines for Interventions in MR Ali AlMasood Mitral regurgitation The most diverse from all acquired valve diseases About 50% of patients with an LVEF 35 percent had moderate to severe

More information

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) UNIVERSITY OF PADUA, SCHOOL OF MEDICINE Department of Cardiac,Thoracic and Vascular Sciences Padua, Italy MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) Luigi P. Badano**, MD, PhD, FESC,

More information

Mitral Repair/AF Ablation Sternotomy Approach

Mitral Repair/AF Ablation Sternotomy Approach Mitral Repair/AF Ablation Sternotomy Approach Patrick M. McCarthy MD, FACC Executive Director of the Bluhm Cardiovascular Institute Chief of Cardiac Surgery Division Heller-Sacks Professor of Surgery in

More information

Next Generation Therapies: Aortic, Mitral and Beyond

Next Generation Therapies: Aortic, Mitral and Beyond Next Generation Therapies: Aortic, Mitral and Beyond Scott M Lilly, MD PhD Medical (Interventional) Director, Structural Heart Program Heart Summit, Lima OH August 26 th, 2017 Next Generation Therapies:

More information

Imaging to select patients for Transcatheter TV

Imaging to select patients for Transcatheter TV Imaging to select patients for Transcatheter TV Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands San Diego, february 2018 Research grants: Medtronic, Biotronik, Boston Scientific,

More information

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? Prof. Patrizio LANCELLOTTI, MD, PhD GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège, CHU

More information

Haiping Wang 1,2, Xiancheng Liu 2, Xin Wang 2, Zhenqian Lv 2, Xiaojun Liu 2, Ping Xu 1. Introduction

Haiping Wang 1,2, Xiancheng Liu 2, Xin Wang 2, Zhenqian Lv 2, Xiaojun Liu 2, Ping Xu 1. Introduction Original Article Comparison of outcomes of tricuspid annuloplasty with 3D-rigid versus flexible prosthetic ring for functional tricuspid regurgitation secondary to rheumatic mitral valve disease Haiping

More information

3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD

3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD 3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD Asan Medical Center University of Ulsan College of Medicine Seoul, Korea Causes of TR Primary causes (25%) Rheumatic Myxomatous

More information

Surgical repair techniques for IMR: future percutaneous options?

Surgical repair techniques for IMR: future percutaneous options? Surgical repair techniques for IMR: can this teach us about future percutaneous options? Genk - Belgium Prof. Dr. R. Dion KULeu Disclosure slide Robert A. Dion I disclose the following financial relationships:

More information

Tricuspid leaflet repair: innovative solutions

Tricuspid leaflet repair: innovative solutions Perspective Tricuspid leaflet repair: innovative solutions Jack H. Boyd 1, J. James B. Edelman 2, David H. Scoville 1, Y. Joseph Woo 1 1 Department of Cardiothoracic Surgery, Stanford University School

More information

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation

More information

Isolated tricuspid valve surgery: timing and indications

Isolated tricuspid valve surgery: timing and indications Cartagena de Indias, Colombia. September 2017 Isolated tricuspid valve surgery: timing and indications José L. Pomar, MD, PhD Professor of Surgery The Cardiovascular Institute Hospital Clinic and University

More information

Aortic valve repair: When and how to employ this novel approach?

Aortic valve repair: When and how to employ this novel approach? Aortic valve repair: When and how to employ this novel approach? Konstadinos A Plestis, MD System Chief of Cardiac Thoracic and Vascular Surgery Main Line Health Care System Professor Sidney Kimmel Medical

More information

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος MV anatomy Otto C. NEJM 2001 Leaflets anatomy 2% of population Etiology Terminology

More information

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated? Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should

More information

Surgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan

Surgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan Surgical AF Ablation : Lesion Sets and Energy Sources What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan Disclosures Consultant/Advisory Board: Abbott, Edwards Lifesciences

More information

Risk Factors for Development of Tricuspid Regurgitation after Heart Transplantation and Long-term Outcome of Tricuspid Valve Surgery

Risk Factors for Development of Tricuspid Regurgitation after Heart Transplantation and Long-term Outcome of Tricuspid Valve Surgery Risk Factors for Development of Tricuspid Regurgitation after Heart Transplantation and Long-term Outcome of Tricuspid Valve Surgery Roland Hetzer Anja Claudia Baier Eva Maria Delmo Walter 29 April 2015

More information

Management of Difficult Aortic Root, Old and New solutions

Management of Difficult Aortic Root, Old and New solutions Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult

More information

Techniques for ischemic mitral valve disease: An Update. Stanford CV Surgery

Techniques for ischemic mitral valve disease: An Update. Stanford CV Surgery Techniques for ischemic mitral valve disease: An Update Conflict of Interest Disclosure Grant/ Research Support: NHLBI RO1 HL67025 Consulting Fees/Honoraria: Stanford PI PARTNER Trial, Edwards Lifesciences

More information

Valvular Guidelines: The Past, the Present, the Future

Valvular Guidelines: The Past, the Present, the Future Valvular Guidelines: The Past, the Present, the Future Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief,

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board

More information

Late Outcome of Tricuspid Annuloplasty Using a Flexible Band/Ring for Functional Tricuspid Regurgitation

Late Outcome of Tricuspid Annuloplasty Using a Flexible Band/Ring for Functional Tricuspid Regurgitation Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp ORIGINAL ARTICLE Cardiovascular Surgery Late Outcome of Tricuspid Annuloplasty Using a Flexible Band/Ring

More information

Concomitant tricuspid valve repair in patients with minimally invasive mitral valve surgery

Concomitant tricuspid valve repair in patients with minimally invasive mitral valve surgery Featured Article Concomitant tricuspid valve repair in patients with minimally invasive mitral valve surgery Bettina Pfannmüller, Piroze Davierwala, Gregor Hirnle, Michael A. Borger, Martin Misfeld, Jens

More information

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid Patient records 76 y.o. male Hypertension. Dyslipidemia. OPLD. Smoked in the past. Diabetes

More information

Quality Outcomes Mitral Valve Repair

Quality Outcomes Mitral Valve Repair Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding

More information

Aortic valve repair: Techniques and Pitfalls. Allan Stewart, MD Columbia University Medical Center New York, NY

Aortic valve repair: Techniques and Pitfalls. Allan Stewart, MD Columbia University Medical Center New York, NY Aortic valve repair: Techniques and Pitfalls Allan Stewart, MD Columbia University Medical Center New York, NY Take Away Points 1. Valve anatomy is essential to assess repair 2. Unique Decisions with Aneurysm/AI

More information

Surgical Ablation: Which Lesion Set for Which Patient?

Surgical Ablation: Which Lesion Set for Which Patient? Surgical Ablation: Which Lesion Set for Which Patient? Patrick M. McCarthy MD, FACC Director of the Bluhm Cardiovascular Institute Chief of Cardiac Surgery Division Heller-Sacks Professor of Surgery in

More information

Prognostic Impact of FMR

Prognostic Impact of FMR Secondary Mitral Valve Regurgitation in Heart Failure, Age 60 Years From Medical Therapy to Surgical Repair to Transcatheter Intervention The Interventionalist s View Samin K Sharma, MD, FACC, FSCAI Director

More information

Which patient undergoing mitral valve surgery should also have the tricuspid repair?

Which patient undergoing mitral valve surgery should also have the tricuspid repair? doi:10.1510/icvts.2009.217570 Interactive CardioVascular and Thoracic Surgery 9 (2009) 1009 1020 www.icvts.org Best evidence topic - Valves Which patient undergoing mitral valve surgery should also have

More information

Repair for Aortic Regurgitation: is it durable?

Repair for Aortic Regurgitation: is it durable? Repair for Aortic Regurgitation: is it durable? Gébrine El Khoury Cliniques Universitaires St-Luc, IREC, UCL, Brussels, Belgium AATS 95 th Annual Meeting 25-29 April, Seattle Aorrtic valve repair the basics

More information

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain Device Landscape 2010 PERCUTANEOUS TECHNIQUES Percutaneous indirect annuloplasty Percutaneous direct annuloplasty Edge to Edge ( E-Valve ) Non

More information

Pulmonary Valve Replacement

Pulmonary Valve Replacement Pulmonary Valve Replacement Christian Kreutzer MD Hospital Nacional Alejandro Posadas Hospital Universitario Austral (No disclosures) Scope of the problem. CHD with PS or PA require a RVOT procedure. Tetralogy

More information

Surgical Approach To Functional MR: One Size Does Not Fit All

Surgical Approach To Functional MR: One Size Does Not Fit All 1 Surgical Approach To Functional MR: One Size Does Not Fit All Pavan Atluri, M.D Associate Professor of Surgery Director, Mechanical Circulatory Support and Heart Transplantation Director, Minimally Invasive

More information

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,

More information

Aortic Stenosis Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Aortic Stenosis Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan Aortic Stenosis - 2011 Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan Aortic Surgery Aortic Stenosis EB CT - Ca++ everywhere! Surgery for Aortic Stenosis 100,000 USA + 100,000

More information

Evolving Indications for Tricuspid Valve Surgery

Evolving Indications for Tricuspid Valve Surgery Current Treatment Options in Cardiovascular Medicine (2010) 12:587 597 DOI 10.1007/s11936-010-0098-1 Valvular, Myocardial, Pericardial, and Cardiopulmonary Diseases Evolving Indications for Tricuspid Valve

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

Indications and Late Results of Aortic Valve Repair

Indications and Late Results of Aortic Valve Repair Indications and Late Results of Aortic Valve Repair Prof. Gebrine El Khoury Department of Cardiovascular and Thoracic Surgery Cliniques St. Luc Brussels, Belgium Aortic Valve Repair Question # 1 Can the

More information

Tricuspid valve surgery in patients with a systemic right ventricle

Tricuspid valve surgery in patients with a systemic right ventricle Tricuspid valve surgery in patients with a systemic right ventricle Roderick Scherptong, Hubert Vliegen, Michiel Winter, Barbara Mulder, Ernst van der Wall, Dave Koolbergen, Mark Hazekamp Eduard Holman,

More information

Valvular Intervention

Valvular Intervention Valvular Intervention Outline Introduction Aortic Stenosis Mitral Regurgitation Conclusion Calcific Aortic Stenosis Deformed Eccentric Calcified Nodular Rigid HOSTILE TARGET difficult to displace prone

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Management of TR in Patients Undergoing Mitral Interventions

Management of TR in Patients Undergoing Mitral Interventions Management of TR in Patients Undergoing Mitral Interventions Stephen H. Little, MD John S. Dunn Chair in Cardiovascular Research and Education, Associate professor, Weill Cornell Medicine shlittle@houstonmethodist.org

More information

Assessing the Impact on the Right Ventricle

Assessing the Impact on the Right Ventricle Advances in Tricuspid Regurgitation Congress of the European Society of Cardiology (ESC) Munich, August 25-29, 2012 Assessing the Impact on the Right Ventricle Stephan Rosenkranz, MD Clinic III for Internal

More information

Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement. Prakash P Punjabi. FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE

Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement. Prakash P Punjabi. FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement Prakash P Punjabi FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE Consultant Cardiothoracic Surgeon Imperial College Healthcare NHS Trust Hammersmith

More information

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC MitraClip Therapy Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Program Director, Interventional Cardiology Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA

More information

Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip. Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy

Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip. Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy Disclosures I have nothing to disclose FMR: a ventricular

More information

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines Christophe Tribouilloy Amiens, France I have no financial relationships to disclose related

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Indiana Chapter of ACC November 15 th,2008 Percutaneous Mitral Valve Repair James B Hermiller, MD, FACC The Care Group, LLC St Vincent Hospital Indianapolis, IN Mechanisms of Mitral Regurgitation Mitral

More information

Surgery For Ebstein Anomaly

Surgery For Ebstein Anomaly Surgery For Ebstein Anomaly Christian Pizarro, MD Chief, Pediatric Cardiothoracic Surgery Director, Nemours Cardiac Center Alfred I. dupont Hospital for Children Professor of Surgery and Pediatrics Sidney

More information

Annular Stabilization Techniques in the Context of Aortic Valve Repair

Annular Stabilization Techniques in the Context of Aortic Valve Repair Annular Stabilization Techniques in the Context of Aortic Valve Repair Prashanth Vallabhajosyula, MD MS University of Pennsylvania, Philadelphia, Pennsylvania 2 nd North American Aortic Valve Repair Symposium

More information

What is Ebstein Anomaly?

What is Ebstein Anomaly? Echocardiograpnhic Evaluation of : Definition, Detection and Determinants of Outcome P. W. O Leary, M.D. Division of Pediatric Cardiology Mayo Clinic No Conflicts to Disclose What is? Failure of the TV

More information

Persistent Tricuspid Regurgitation After Tricuspid Annuloplasty During Redo Valve Surgery Affects Late Survival and Valve-Related Events

Persistent Tricuspid Regurgitation After Tricuspid Annuloplasty During Redo Valve Surgery Affects Late Survival and Valve-Related Events Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Advance Publication by-j-stage Persistent Tricuspid Regurgitation After Tricuspid Annuloplasty During Redo

More information

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi SC Cardiochirurgia U Universita degli Studi di Torino PORT-ACCESS TECNIQUE Reduce surgical trauma Minimize disruption of the chest wall

More information

Surgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital

Surgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital Mitral Valve Surgical intervention Graham McCrystal Chairs: Rajesh Nair & Gerard Wilkins Surgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital

More information

Index. B B-type natriuretic peptide (BNP), 76

Index. B B-type natriuretic peptide (BNP), 76 Index A ACCESS-EU registry, 158 159 Acute kidney injury (AKI), 76, 88 Annular enlargement, RV, 177 178 Annuloplasty chordal cutting, 113 complete ring, 99 etiology-specific ring, 100 evolution, 98 flexible

More information

What is the Role of Surgical Repair in 2012

What is the Role of Surgical Repair in 2012 What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th

More information

2017 Update to the AHA/ACC Guideline for Management of Mitral Valve Disease

2017 Update to the AHA/ACC Guideline for Management of Mitral Valve Disease 2017 Update to the AHA/ACC Guideline for Management of Mitral Valve Disease Patrick T. O Gara, MD BWH Heart and Vascular Center Professor of Medicine, Harvard Medical School Disclosures NHLBI CTSN Co-chair

More information

Ischemic Mitral Regurgitation

Ischemic Mitral Regurgitation Ischemic Mitral Regurgitation 1 / 6 2 / 6 3 / 6 Ischemic Mitral Regurgitation Background Myocardial infarction (MI) can directly cause (IMR), which has been touted as an indicator of poor prognosis in

More information

Objectives. Considerations in management of multivalvular disease. Case Discussions. A Systematic Approach to Multivalve Disease.

Objectives. Considerations in management of multivalvular disease. Case Discussions. A Systematic Approach to Multivalve Disease. A Systematic Approach to Multivalve Disease James D. Thomas, MD, FACC, FASE Director, Center for Heart Valve Disease Bluhm Cardiovascular Institute Professor of Medicine, Feinberg School of Medicine, Northwestern

More information

Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations

Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations Imaging and Diagnostic Testing Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations Jae-Jin Kwak, MD, a Yong-Jin

More information

Aortic stenosis with concomitant mitral regurgitation

Aortic stenosis with concomitant mitral regurgitation Challenges in the evaluation and management of aortic stenosis Aortic stenosis with concomitant mitral regurgitation S1 Philippe Unger, M.D., FESC Erasme Hospital - Université Libre de Bruxelles Brussels,

More information

Valvular Heart Disease Transcatheter Valve Therapies. October 2016 Brian Whisenant MD

Valvular Heart Disease Transcatheter Valve Therapies. October 2016 Brian Whisenant MD Valvular Heart Disease Transcatheter Valve Therapies October 2016 Brian Whisenant MD Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement

More information

Right Ventricular Failure: Prediction, Prevention and Treatment

Right Ventricular Failure: Prediction, Prevention and Treatment Right Ventricular Failure: Prediction, Prevention and Treatment 3 rd European Training Symposium for Heart Failure Cardiologists and Cardiac Surgeons University Hospital Bern June 24-25, 2016 Disclosures:

More information

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC NATURAL HISTORY OF MITRAL REGURGITATION Abdallah El Sabbagh et al. JIMG 2018;11:628-643 TREATMENT OPTIONS SURGERY REPAIR REPLACEMENT PERCUTANEOUS INTERVENTIONS

More information

Aortic Valve Repair: The Brussels Approach Laurent de Kerchove, MD, PhD Cliniques Universitaires St-Luc, IREC, UCL, Brussels, Belgium

Aortic Valve Repair: The Brussels Approach Laurent de Kerchove, MD, PhD Cliniques Universitaires St-Luc, IREC, UCL, Brussels, Belgium Reconstruction of the Aortic Valve and Root: A Practical Approach September 14 th -16 th, Homburg/Saar, Germany Aortic Valve Repair: The Brussels Approach Laurent de Kerchove, MD, PhD Cliniques Universitaires

More information

Indications and Outcomes of the Double Switch in cctga. David Barron Birmingham, UK

Indications and Outcomes of the Double Switch in cctga. David Barron Birmingham, UK Indications and Outcomes of the Double Switch in cctga David Barron Birmingham, UK No Disclosures cctga: The Problem cctga does not fit into neat, clincially discrete sub-groups Atrial Situs Wide range

More information

Chronic Primary Mitral Regurgitation

Chronic Primary Mitral Regurgitation Chronic Primary Mitral Regurgitation The Case For Early Surgical Intervention William K. Freeman, MD, FACC, FASE DISCLOSURES Relevant Financial Relationship(s) None Off Label Usage None Watchful Waiting......

More information

-The Living Aortic Valve- Repair or Else? Ismail El-Hamamsy, MD PhD

-The Living Aortic Valve- Repair or Else? Ismail El-Hamamsy, MD PhD -The Living Aortic Valve- Repair or Else? Ismail El-Hamamsy, MD PhD Associate Professor Director, Aortic Surgery Division of Cardiac Surgery Montreal Heart Institute Université de Montreal PhD Thesis Imperial

More information

SONOGRAPHER & NURSE LED VALVE CLINICS

SONOGRAPHER & NURSE LED VALVE CLINICS SONOGRAPHER & NURSE LED VALVE CLINICS Frequency of visits and alerts AORTIC STENOSIS V max > 4.0 m/s or EOA < 1.0 cm 2 V max 3.5 4.0 m/s + Ca+ V max 3.0 4.0 m/s or EOA 1.0-1.5 cm 2 V max 2.5 3.0 m/s every

More information

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017 James S. Gammie, MD Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical The Houston Aortic Symposium February 2-25, 2017 Disclosure Statement of Financial Interest Within

More information

Minimally invasive therapies for the mitral valve: How will you incorporate into your clinical practice? Guilherme F.

Minimally invasive therapies for the mitral valve: How will you incorporate into your clinical practice? Guilherme F. Minimally invasive therapies for the mitral valve: How will you incorporate into your clinical practice? Guilherme F. Attizzani, MD UH Harrington Heart and Vascular Institute Interventional Cardiologist/Structural

More information

Get Ready for Percutaneous Mitral Valve Approaches

Get Ready for Percutaneous Mitral Valve Approaches Get Ready for Percutaneous Mitral Valve Approaches Paul A. Grayburn, MD Baylor Scott and White Healthcare System The Heart Hospital Baylor Plano and Baylor Heart and Vascular Hospital Dallas, TX HOPE Unmet

More information

Surgical Options to Prevent and Treat Tricuspid Valve Regurgitation in Heart Transplant Recipients

Surgical Options to Prevent and Treat Tricuspid Valve Regurgitation in Heart Transplant Recipients Surgical Options to Prevent and Treat Tricuspid Valve Regurgitation in Heart Transplant Recipients Alejandro Bertolotti, MD Favaloro Foundation Argentina Disclosure: Conflict Of Interest Nothing to disclose

More information

Emergency Intraoperative Echocardiography

Emergency Intraoperative Echocardiography Emergency Intraoperative Echocardiography Justiaan Swanevelder Department of Anaesthesia, Glenfield Hospital University Hospitals of Leicester NHS Trust, UK Carl Gustav Jung (1875-1961) Your vision will

More information

Joseph E. Bavaria, M.D. Roberts Measy Professor and Vice Chief CardioVascular Surgery Director: Thoracic Aortic Surgery Program University of

Joseph E. Bavaria, M.D. Roberts Measy Professor and Vice Chief CardioVascular Surgery Director: Thoracic Aortic Surgery Program University of Joseph E. Bavaria, M.D. Roberts Measy Professor and Vice Chief CardioVascular Surgery Director: Thoracic Aortic Surgery Program University of Pennsylvania, USA North American Valve Repair, Philadelphia

More information

Case Studies in Complex Endocarditis

Case Studies in Complex Endocarditis Case Studies in Complex Endocarditis Vera H. Rigolin, MD Professor of Medicine Northwestern University Feinberg School of Medicine Medical Director, Echocardiography Laboratory Northwestern Memorial Hospital

More information

Management of HOCM: Non-Surgical Options

Management of HOCM: Non-Surgical Options Management of HOCM: Non-Surgical Options Howard C. Herrmann, MD, FACC, MSCAI John Bryfogle Professor of Cardiovascular Medicine and Surgery Health System Director for Interventional Cardiology Director,

More information

AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville,

AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville, AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville, Virginia AATS Ischemic MR Guideline Writing Group Roster

More information